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Background: There is a general paucity of cysteine residues within the passenger domains of autotransporter proteins.
Results: Distantly spaced cysteines forming disulfide-bonded loops or those enclosing structural elements are
secretion-incompetent.
Conclusion:Only closely spaced cysteine pairs are compatible with the autotransporter pathway.
Significance: Secretion of folded peptides by the autotransporter pathway is limited; hence autotransporters lack large disul-
fide-bonded loops to remain secretion-competent.
Autotransporters are a superfamily of virulence factors typi-
fied by a channel-forming C terminus that facilitates transloca-
tion of the functional N-terminal passenger domain across the
outer membrane of Gram-negative bacteria. This final step in
the secretion of autotransporters requires a translocation-com-
petent conformation for the passenger domain that differs
markedly from the structure of the fully folded secreted protein.
The nature of the translocation-competent conformation
remains controversial, in particular whether the passenger
domain can adopt secondary structural motifs, such as disul-
fide-bonded segments, while maintaining a secretion-compe-
tent state. Here, we used the endogenous and closely spaced
cysteine residues of the plasmid-encoded toxin (Pet) from
enteroaggregative Escherichia coli to investigate the effect of
disulfide bond-induced folding on translocation of an auto-
transporter passenger domain. We reveal that rigid structural
elements within disulfide-bonded segments are resistant to
autotransporter-mediated secretion.We define the size limit of
disulfide-bonded segments tolerated by the autotransporter
system demonstrating that, when present, cysteine pairs are
intrinsically closely spaced to prevent congestion of the translo-
cator pore by large disulfide-bonded regions. These latter data
strongly support the hairpin mode of autotransporter
biogenesis.
Gram-negative bacteria possess seven secretion pathways
(numbered I–VI and the chaperone-usher pathway) that facil-
itate navigation of secreted proteins through the inner mem-
brane, periplasm, and outermembrane (OM).2 These pathways
generally use specializedmachineries that span the width of the
cell envelope and that differ in complexity, structural features,
and mechanism of protein translocation. At first glance, the
simplicity of the type Va secretion pathway appeared to be the
exception; all the functional elements required for secretion
appeared to be containedwithin a single proteinwith theN-ter-
minal signal peptide mediating inner membrane translocation,
the central passenger domain being the secreted functional
moiety, and the C terminus forming a -barrel structure in the
OM, the latter element being essential for passenger domain
translocation to the bacterial cell surface. Accordingly, the
superfamily of proteins that exploit this pathway for their deliv-
ery to the surface of Gram-negative bacteria was termed auto-
transporters (ATs) (1).
However, recent studies demonstrating that passenger
domain secretion requires the aid of accessory factors have
challenged the theory thatATs are self-contained secretion sys-
tems; periplasmic chaperones SurA, Skp, and DegP have been
implicated in AT biogenesis (2–5), as have BamA and BamD
(5–8), the essential components of the OM -barrel assembly
machinery (BAM), which functions in concert to insert into the
OMcorrectly folded integral outermembrane proteins (OMPs)
that adopt a -barrel conformation (9). Although it is clear that
ATs associate closely and tightly with BamA and BamD during
OM translocation (5, 10–12), the precise nature of these inter-
actions is unknown. Certainly, it still remains to be elucidated
how these components facilitate the integration of AT -do-
mains and other -barrel OMPs into the lipid bilayer. Never-
theless, when inserted into the OM, the AT -domain forms a
-barrel structure reminiscent of most other integral OMPs
(13–18). Consistent with early bioinformatic studies, which
suggested that the AT -domain is evolutionarily and structur-
ally conserved (19), almost perfectly superimposable crystal
structures of the -domain of five monomeric ATs have been
reported (14–18). Each structure demonstrated a 12-stranded
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-barrel adjoined by periplasmic turns and extracellular loops
of varying length, with a narrow hydrophilic pore.
After insertion of theAT-barrel into theOM, translocation
through the -barrel pore was thought to begin by the forma-
tion of a hairpin structure at themost C-terminal portion of the
passenger domain, termed the autochaperone domain. There is
now a substantial body of evidence demonstrating that the
autochaperone domain emerges from the bacterial cell first and
folds into a stable protease-resistant structure, whichmay drive
folding of the remaining passenger domain and subsequent
translocation across the OM in the absence of external energy
sources (11, 20–23). OM translocation is dependent on a pas-
senger domain conformation that differs from the final protein
structure, which for most ATs is a characteristic right-handed
-helical stalk-like structure connected by various loops, some
of which are presumed to confer functionality (21, 23–27).
The conformation of the passenger domain has important
implications for secretion. Originally, it was hypothesized that
the passenger domain was maintained in a linear state during
secretion and that folding occurred only after translocation (1).
However, other studies have challenged this model, suggesting
that folded elements can readily be secreted to the bacterial
surface (29, 30). Studies investigating this relationship between
the folding and secretion of AT passenger domains have largely
focused on disulfide bond formation during transit through the
periplasm, between exogenous Cys residues introduced into
passenger domains (20, 28), or between Cys residues within
heterologous passenger domains (29–36). Although the trans-
location of sizable folded domains comprising disulfide-
bonded segments of heterologous passenger domains was
reported (30–32), a greater number of studies have demon-
strated that periplasmic formation of either long disulfide-
bonded loops or tightly folded/rigid structures is incompatible
withOM translocation/secretion of ATpassenger domains (20,
28, 29, 33–36). These dichotomous sets of studies have given
rise to twomechanisticmodels ofATbiogenesis, one proposing
that passenger domain translocation occurs through a folded
AT -barrel pore, and the other proposing BamA as an acces-
sory factor mediating passenger translocation before the -do-
main adopts a final folded conformation.
Here, we used the plasmid-encoded toxin (Pet), a prototypi-
cal member of the serine protease ATs of the Enterobacteri-
aceae (SPATEs) (37), to ascertain the tolerance for folded ele-
ments during OM translocation. Pet possesses a pair of
endogenous Cys residues separated by 4 amino acids that are
located within a region of the passenger protein termed
domain-2A (D2A), which is roughly 50 amino acids in length
and is present only in the serine protease ATs of the Enterobac-
teriaceae that elicit toxic effects on eukaryotic cells (supple-
mental Fig. S1). We systematically determine the maximum
length of a disulfide-bonded loop that does not interfere with
translocation, providing data that strongly support the hairpin
mode of AT biogenesis. In addition, we demonstrate that when
present, native Cys pairs within AT passenger domains are
intrinsically closely spaced to avoid jamming of the translocator
pore by large disulfide-bonded regions.
EXPERIMENTAL PROCEDURES
Reagents, Media, and Bacterial Strains—A polyclonal rabbit
antiserum generated toward the Pet passenger domain (37) and
BamA and BamD (8) have been previously described. Anti-
FLAG tag antibody raised in rabbits and Alexa Fluor 488 goat
anti-rabbit IgG (HL) were purchased from GenScript and
Invitrogen, respectively. Anti-HA tag antibody produced in
rabbits, alkaline phosphatase-conjugated goat anti-rabbit anti-
bodies, and the alkaline phosphatase substrate 5-bromo-4-
chloro-3-indolylphosphate were obtained from Sigma-Aldrich.
Bacteria were grown at 37 ºC in Luria-Bertani (LB) broth, and
where necessary, the growth medium was supplemented with
100 g/ml ampicillin, 50 g/ml kanamycin, 2% D-glucose, or
0.02% L-arabinose. The Escherichia coli strains used in this
study were TOP10 (Invitrogen) and BW25113 dsbA::kan (38).
Plasmid Construction—Plasmids used in this study are listed
in supplemental Table S1. pBADPet has been described previ-
ously (39). A 363-bp SpeI-XbaI fragment comprising sequence
coding for PetwithoutD2Awas synthesizedde novo and cloned
into pUC57 (GenScript). pUC57D2A was digested with SpeI
and XbaI and subcloned into pBADPet, predigested with the
same restriction enzymes, to create pBADPetD2A. To con-
struct pUC57SB and pUC57L4HA, 624- and 771-bp fragments,
respectively, were synthesized de novo and cloned into pUC57.
pUC57SB and pUC57L4HA were digested separately with SalI
and KpnI and with HpaI and EcoRI and subcloned into pBAD-
Pet, predigested with the same restriction enzymes, to create
pBADPetSB and pBADPetL4HA, respectively. The Pet deriva-
tives comprising one, two, and three HA epitope tags between
the Cys pair in D2A were generated through de novo synthesis
of 362-, 389-, and 416-bp SpeI-BsrGI fragments, respectively,
that were then cloned into pUC57. pUC571HA, pUC572HA,
and pUC573HA were digested with SpeI and BsrGI and sub-
cloned into pBADPet, predigested with the same restriction
enzymes, to create pBADPet1HA, pBADPet2HA, and
pBADPet3HA, respectively. A 335-bp de novo synthesized frag-
ment with Cys-12/Cys-17 mutated to Gly and His-1/Ser-50
mutated to Cys was cloned into pUC57 to create pUC5748aa.
This vector was digested with SpeI and BsrGI and subcloned
into pBADPet, predigested with the same restriction enzymes,
to generate pBADPet48aa. The latter expresses a Pet derivative
where the Cys residues are separated by 48 amino acids.
To construct pBADPetC12G, pBADPet6aa, pBADPet8aa,
pBADPet10aa pBADPet12aa, pBADPet14aa, pBADPet16aa,
and pBADPet9G,megaprimer PCRwas performed as described
previously (40) with some variation. Briefly, all round 1 PCRs
were performed on 500 ng of template DNA (pBADPet) with 1
g of the appropriate mutagenesis primer always in combina-
tion with 1 g of primer BsrGIRv per 100 l of reaction mix-
ture. Round 1 PCRs were then purified to remove residual
primers from the megaprimer synthesized in this first round of
amplification. Round 2 PCRs were performed with 4 g of
megaprimer and 1 g of primer SpeIFw on 500 ng of template
DNA (pBADPet) per 100 l of reaction mixture. Round 2
amplicons and target vector (pBADPet) were then digested
with SpeI and BsrGI and ligated. Constructs pBADPetC12G/
C17G, pBADPet18aa, and pBADPet20aa were generated
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exactly as described above with the exception that
pBADPetC12G was used as template DNA. The megaprimer
PCR method was also used to generate pBADPet1HA-FLAG
through insertion of a FLAG epitope tag between residues Gly-
837 and Phe-838. Round 1 PCR was performed as described
above using pBADPet as template DNA and the appropriate
mutagenesis primer with primer SalIRv. Round 2 PCR ensued
using primer BsrGIFw, and the subsequent amplicon and target
vector (pBADPet) were then digested with BsrGI and SalI and
ligated. pBADPet1HA-FLAG was digested with BsrGI and SalI
and subcloned into pBADPetSB predigested with the same
restriction enzymes to create pBADPetSB-FLAG. Primers used
in this study are listed in supplemental Table S2.
Construction of an E. coli TOP10 dsbA Mutant—The  Red
recombinase system (41) was used to construct an in-frame
dsbA knock-out mutant of E. coli TOP10.
Analysis of Pet Biogenesis—Growth, expression, and precipi-
tation of Pet from TOP10 and TOP10 dsbA::kan transformed
with pBADPet derivatives were performed as described previ-
ously (39). Where necessary, 10 mM -mercaptoethanol
(-ME; Sigma-Aldrich) was added to the culture medium to
reduce disulfide bonds formed in the periplasm (20). Superna-
tant proteins were separated by SDS-PAGE and detected by
staining with Coomassie Brilliant Blue R250 (BDH Laboratory
Supplies) orWestern immunoblotting using anti-Pet passenger
antibody.
Immunofluorescence Microscopy—Fixation and permeabili-
zation of TOP10 cells transformed with pBADPet derivatives
were performed as described previously (42). Preparation of
cells for live cell imagingwas performed as described previously
(43) with minor modifications; poly-L-lysine-coated coverslips
loaded with either fixed or live cells were washed three times
with PBS, and nonspecific binding sites were blocked for 1 h in
PBS containing 1% BSA (Europa Bioproducts). Coverslips were
incubated with anti-Pet passenger, anti-HA tag, or anti-FLAG
tag antibody for 1 h, washed three times with PBS, and incu-
bated for an additional 1 h with Alexa Fluor 488 goat anti-
rabbit IgG. The coverslips were then washed three times with
PBS, mounted onto glass slides, and visualized using either
phase contrast or fluorescence using a Zeiss AxioImager Z2
microscope (100 objective) and an AxioCam MRm camera.
Exposure time was 40 ms.
ThiolModifications—Thiolmodification reactions were per-
formed to determine the presence or absence of disulfide bond
formation in Pet using the thiol-specific reagent, mPEG-
maleimide-10,000 Da (mPEG-Mal) (Sigma-Aldrich). Briefly,
Pet from TOP10 cells transformed with pBADPet derivatives
was expressed, and clarified supernatants were concentrated
100-fold as described previously (39). Supernatants were buf-
fer-exchanged into thiol modification buffer (50 mM Tris, pH
7.5), and protein concentrations were calculated using Brad-
ford protein assay reagent according to the manufacturer’s
instructions (Bio-Rad). mPEG-Mal was suspended in dimethyl
sulfoxide (DMSO) as a 40 mM stock solution and used immedi-
ately. Briefly, 30 g of protein, sometimes pretreated with 10
mM Tris(2-carboxyethyl) phosphine (Sigma-Aldrich) for 1 h at
room temperature, wasmixedwith 10mMmPEG-Mal in a final
volume of 30 l (topped up with thiol modification buffer
where necessary) and incubated overnight at 4 ºC. TCEP-
treated (reduced) and untreated (oxidized) samples weremixed
with the same volume of non-reducing SDS-sample buffer
(2), resolved on 4–20% gradient Precise protein gels in Tris-
HEPES-SDS buffer (Thermo Fisher Scientific), and localized by
Western immunoblotting using anti-Pet passenger antibody.
Pet Purification and Circular Dichroism Spectroscopy—
TOP10 cells transformed with pBADPet and pBADPetD2A
expressed Pet, and clarified supernatants were concentrated as
described above. Pet and PetD2A were purified, and far-UV
CD spectra were collected as described previously (21) except
that Pet derivatives were purified using a HiLoad 16/60 Super-
dex 75 gel filtration column (GE Healthcare), and far-UV CD
measurements were collected from 190 to 260 nm on a JASCO
J-715 spectropolarimeter at room temperature with a 1-mm
path length cell, 2-nm bandwidth, 1-nm increments, 2-s
response, 100 nm/min scanning speed, and continuous scan-
ning mode. Eight scans were averaged, and the spectrum was
subtracted for buffer contribution.
Co-immunoprecipitation—Chemical cross-linking, sphero-
plast formation, and lysis of E. coli cultures for co-immunopre-
cipitation of BamA and BamD were performed as described
previously (44). A total of 4 g of anti-Pet passenger domain
antibodywas added into the cleared lysate, and themixture was
shaken for 1 h. A total of 60 l of protein A-Sepharose beads
(Sigma-Aldrich) was added to the lysate-antibody mixture,
which was shaken for an additional 1 h. Beads within this mix-
ture were pelleted (3,000  g, 1 min) and washed three times
with 1 ml of Pierce IP lysis buffer (Thermo Fisher Scientific)
followed by one wash with 1 ml of PBS. Boiling in 50 l of
sample buffer containing DTT served to elute the proteins and
to reverse the cross-linking reaction. The eluted fractions were
centrifuged as above to completely remove the beads and sep-
arated on NuPAGE 4–12% gradient Bis-Tris gels in MES
buffer (Invitrogen). Western immunoblotting was carried out
using rabbit polyclonal antibodies against the Pet passenger
domain, BamA and BamD.
RESULTS
Native Cys Residues Are Not Required for Secretion or Folding
of Pet—With the exception of several polymorphic ATs of
Chlamydia (45), a feature of AT proteins is the general paucity
of Cys residues within the secreted passenger proteins. Where
multiple Cys residues are present, the distances between the
Cys pairs generally range from a minimum of 3 residues to a
maximum of only 17 residues (46) (supplemental Table S3). It
has previously been suggested that paired Cys residues found
within AT passenger proteins are required for the correct bio-
genesis of ATs (46, 47). The Pet AT possesses a pair of endog-
enous Cys residues separated by 4 amino acids that are located
within D2A. To determine the location of D2A, a three-dimen-
sional model of Pet was built using the crystal structure of the
homologous Hbp AT protein (26) (Fig. 1A). The model reveals
that like Hbp, Pet possesses a serine protease domain (D1),
which is N-proximal to the -helix. In the case of Hbp, discur-
sive loops extend from the central -helix at different points to
form D2 and D3 (25, 26). Both domains are lacking from Pet.
However, Pet possesses D2A in place of D3, and the Pet amino
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acid sequence directly adjacent to D2A (QPDWET) is almost
completely conserved with Hbp (supplemental Fig. S1); it has
been shown that these residues provide a platform for the pro-
jection of a stable external loop capable of independent move-
ment (48). Thus, our model predicts that D2A contacts D1 and
returns to the -helical stem close to the point of departure
such that theCys residues do not formpart of the central-hel-
ical stem.
The model of the Pet passenger domain does not suggest an
obvious reason why the Cys residues may influence passenger
domain translocation. To determine whether the paired Cys
residues or D2A were required for Pet biogenesis, culture
supernatant fractions fromE. coli cells expressingwild-type Pet
(pBADPet) (39) and a D2A deletion construct (PetD2A;
pBADPetD2A) were analyzed for the presence of proteins
(Fig. 1B). SDS-PAGE demonstrated that Pet lacking D2A accu-
mulated in the extracellular fraction at levels indistinguishable
from wild-type Pet, indicating that D2A is not required for the
expression, processing, or secretion of Pet. In addition, wild-
type Pet and PetD2A were purified to 90% purity using gel
filtration chromatography (Fig. 1C), and foldingwasmonitored
by far-UVCD spectroscopy. The far-UVCD spectra of both Pet
and PetD2A are indicative of a folded structure rich in
-sheet, with characteristicmaxima andminima between 195–
200 nm and 210–220 nm, respectively (Fig. 1D). AlthoughD2A
appears not to be required for folding of the -helix, PetD2A
displayed a small blue shift in wavelength maxima and minima
(3 nm), conceivably reflecting a minor change in secondary
structure in the D2A deletion mutant. To confirm that the Cys
pair formed a disulfide bond, themature secreted proteins were
incubated with mPEG-Mal, in the presence or absence of
TCEP, which specifically reduces disulfide bonds; mPEG-Mal
interacts specifically with free thiol groups (Fig. 2C). Consistent
with the lack of Cys residues, pegylation of PetD2A was not
observed in the presence or absence of TCEP. In contrast, wild-
type Pet was labeled with mPEG-Mal only under reduced con-
ditions. Because faint high molecular weight bands were evi-
dent in both Pet and PetD2A under oxidizing conditions
(TCEP), they were therefore deemed nonspecific. These
studies indicate that the paired Cys residues form disulfide
bonds that are not required for the biogenesis of Pet.
Large Disulfide-bonded Loops Abolish Secretion of Pet—The
nature of AT passenger domain translocation across the OM
remains controversial. To address the conflicts arising from
these datasets (20, 28–36) and to avoid artifacts that could
result from heterologous constructs, we wished to address the
issue of passenger domain translocation using an AT passenger
domain that possesses endogenously paired Cys residues. The
distances between endogenous Cys pairs in AT passenger
domains generally range from a minimum of 3 residues to a
maximum of only 17 residues (46) (supplemental Table S3). As
such we hypothesized that Cys pairs separated by more amino
acids would form disulfide-bonded loops in the periplasm that
would block secretion. To test this hypothesis, we created
pBADPet20aa and pBADPet48aa encoding mutant Pet pro-
teins (Pet20aa andPet48aa) inwhich the positions of the endog-
enous Cys residues within D2A of the Pet passenger domain
were altered such that they were positioned 20 and 48 amino
acids apart (Fig. 2A and supplemental Fig. S2). SDS-PAGE anal-
FIGURE 1. The Cys residues and D2A are not required for secretion or
folding of Pet. A, a three-dimensional model of the Pet passenger domain
showing D1 and the -helix in blue, D2A in green sticks, the Cys pair in red
spheres, and the semiconserved stable platform in yellow sticks. B, SDS-PAGE
analysis of TCA-precipitated culture supernatant fractions harvested after
growth of TOP10 expressing empty vector (EV), Pet, and PetD2A.M, molec-
ular mass markers. C, SDS-PAGE analysis of concentrated supernatants from
TOP10 expressing Pet and PetD2A before (lane a) and after (lane b) gel fil-
tration chromatography. D, far-UV CD spectra of Pet (open squares) and
PetD2A (closed triangles) in millidegrees (mdeg) showing maxima and min-
ima at 199 and 217 nm and 196 and 214 nm, respectively.
FIGURE 2. Large disulfide-bonded regions abolish secretion of Pet. A,
alignment of D2A from Pet derivatives showing site-directed mutations that
sequentially increased thedistancebetween the endogenousCys pair inD2A
(PetWt) until OM translocation and secretion of the Pet passenger domain
were stalled and abolished, respectively. Endogenous and exogenous Cys
pairs are in bold font, and residues mutated to Gly are in bold font and under-
lined. Although D2A resides within residues 575–624 of the full-length pro-
tein, the numbers on top correspond to the position of each residue within
D2A from His-1 to Ser-50. B, SDS-PAGE analysis of TCA-precipitated culture
supernatant fractions harvested after growthof TOP10 (top panel) and TOP10
dsbA (bottom panel) expressing wild-type Pet (Wt4aa) and Pet6aa to
Pet48aa. M, molecular mass markers. C, mPEG-Mal labeling of wild-type Pet
(Wt4aa), PetD2A, and Pet6aa to Pet48aa in the presence and absence of
TCEP. Supernatants were harvested and concentrated after growth of TOP10
cells expressing wild-type Pet, PetD2A, and Pet6aa to Pet48aa. Samples
were resolved on a gradient 4–20% Tris-HEPES-SDS-PAGE gel, and Pet was
localized by Western immunoblotting using anti-Pet passenger antibody.
The arrow indicates labeled/pegylated Pet, and the asterisk shows unlabeled/
unpegylated Pet.
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ysis of culture supernatant fractions derived from E. coli
pBADPet20aa and pBADPet48aa revealed that Pet20aa and
Pet48aawere not secreted into the culturemedium (Fig. 2B, top
panel). In contrast, when expressed in a strain lacking DsbA,
stalling of passenger domain translocation across the OM was
circumvented, and both proteins accumulated in the extracel-
lular fraction (Fig. 2B, bottom panel). These results suggest that
the 20 and 48 amino acids separating the Cys pairs in Pet20aa
and Pet48aa, respectively, form disulfide-bonded loops that are
too large to migrate through the diameter of the translocator
pore, thereby stalling OM translocation and the subsequent
secretion of the Pet passenger domain.
Having established that disulfide-bonded loops of 20 and 48
amino acids were incompatible with AT passenger domain
translocation, we next set about determining the maximum
number of endogenous residues that can form a disulfide-
bonded loop that is tolerated by the translocator pore.We used
site-directed mutagenesis to sequentially increase the distance
between the Cys pair in D2A such that the Cys residues were
separated by 6 (Pet6aa), 8 (Pet8aa), 10 (Pet10aa), 12 (Pet12aa),
14 (Pet14aa), 16 (Pet16aa), and 18 (Pet18aa) amino acids (Fig.
2A and supplemental Fig. S2). SDS-PAGE analyses of culture
supernatant fractions from E. coli cells expressing Pet6aa to
Pet18aa revealed that allmutant proteins could be secreted into
the culture medium, albeit at reduced levels when compared
with wild type for proteins containing larger disulfide-bonded
loops (Fig. 2B, top panel). Furthermore, in the absence of DsbA,
Pet14aa, Pet16aa, and Pet18aa accumulated in the extracellular
compartment at levels resembling the wild-type protein. Pegy-
lation experiments revealed that Pet6aa, Pet8aa, Pet10aa,
Pet12aa, Pet14aa, Pet16aa, and Pet18aa interacted with mPEG-
Mal only under reduced conditions (TCEP), evidenced by a
shift in themolecular weight of each protein (Fig. 2C), confirm-
ing the presence of a disulfide bond in the mature secreted
species. Overall, our data demonstrate that the longest disul-
fide-bonded loop that does not significantly interfere with OM
translocation of the Pet passenger domain is formed between a
Cys pair separated by 18 residues.
A Rigid Linker Interferes with OM Translocation—Based on
the data above, we hypothesized that the disulfide-bonded
loops of stalled intermediates would be located in the periplas-
mic space. To address this hypothesis, we monitored disulfide
bond-induced folding of the Pet passenger domain during tran-
sit through the periplasm when the distance between the
endogenous Cys pair was increased via the insertion of one,
two, or three HA epitope tags with the following amino acid
sequence, YPYDVPDYA (Fig. 3A, right panel). Because the
endogenous Cys pair within D2A of Pet is separated by 4 amino
acids, the plasmids pBADPet1HA, pBADPet2HA, and
pBADPet3HA encode Pet derivatives where the Cys pairs are
separated by 13 (Pet1HA), 22 (Pet2HA), and 31 (Pet3HA) resi-
dues, respectively. We theorized that Pet1HA would be
secreted but that Pet2HAandPet3HAwould form stalled inter-
mediates. As expected, Pet2HA and Pet3HA did not accumu-
late in the culture supernatant fractions ofE. coli pBADPet2HA
or E. coli pBADPet3HA (Fig. 3A, top and bottom panels). How-
ever, surprisingly, Pet1HAwas not secreted to the extracellular
milieu from E. coli pBADPet1HA. In all three cases, stalling of
passenger domain OM translocation could be circumvented
under conditions preventing intramolecular disulfide bond for-
mation through growth in the presence of reducing agent,
-ME (Fig. 3A, top panel), or in a dsbA background (Fig. 3A,
bottom panel). These latter data indicate that HA epitopes are
not innately resistant to secretion via the AT translocator.
Our results were difficult to reconcile considering that the
disulfide-bonded loop formed with one HA epitope tag was
only 13 residues in length and that we had demonstrated the
capacity of Pet to support the secretion of a passenger domain
with a disulfide-bonded loop composed of 18 amino acids.
Therefore, we decided to investigate whether it was the posi-
tion, the nature, or the length of the HA epitope tag insertion
that obstructed OM translocation of the Pet passenger domain
by creating pBADPet9G, which codes for a Pet derivative
(Pet9G)where the Cys pair is separated by 13 residues due to an
insertion of 9 Gly residues. SDS-PAGE analysis of culture
supernatant fractions from E. coli pBADPet9G revealed that
Pet9G is expressed, processed, and secreted at wild-type levels
in the presence or absence of -ME (Fig. 3B). To determine
whether secretion was unaffected because Pet9G failed to form
a disulfide bond, Pet9G was isolated from the culture superna-
tants and subjected to pegylation using mPEG-Mal in the pres-
ence or absence of TCEP. As a control, we created
pBADPetC12G/C17G, which codes for a Pet derivative where
the endogenous Cys pair has been mutated to Gly. SDS-PAGE
and Western immunoblotting of mPEG-Mal-treated samples
revealed a shift in the molecular weight of Pet9G only under
reduced conditions ( TCEP; Fig. 3C). No such mobility shift
was observed for PetC12G/C17G treated with TCEP, confirm-
ing that the Cys pair in Pet9Gwas disulfide-bonded. These data
FIGURE 3. A rigid linker interferes with OM translocation. A, SDS-PAGE
analysis of TCA-precipitated culture supernatant fractions harvested after
growth of TOP10 and TOP10 dsbA expressing Pet, Pet1HA (1HA), Pet2HA
(2HA), and Pet3HA (3HA). Intramolecular disulfide bond formation was pre-
vented through growth in the presence of -ME (top panel) or in a dsbA
background (bottom panel). A schematic description of the HA epitope tag
insertions is shown on the right. M, molecular mass markers. B, SDS-PAGE
analysis of TCA-precipitated culture supernatant fractions harvested after
growth of TOP10 expressing empty vector (EV), Pet, and Pet9G in the pres-
ence or absence of -ME. C, mPEG-Mal labeling of Pet9G and PetC12G/C17G
in the presence and absence of TCEP. Supernatants were harvested and con-
centrated after growth of TOP10 cells expressing Pet9G and PetC12G/C17G.
Samples were resolved on a gradient 4–20% Tris-HEPES-SDS-PAGE gel, and
Pet was localized byWestern immunoblotting using anti-Pet passenger anti-
body. Thearrow indicates labeled/pegylatedPet, and theasterisk showsunla-
beled/unpegylated Pet.
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indicate that when trapped within a disulfide-bonded loop, it is
the rigid nature of the HA epitope that prevents secretion.
Overall, our results indicate that both the nature and the length
of the amino acid sequences contained between Cys residues
are critical parameters for the translocation competence of pas-
senger domains containing disulfide-bonded segments.
Stalled Intermediates Possess a Hairpin Conformation—
Conceivably, OM translocation of Pet20aa, Pet48aa, Pet1HA,
Pet2HA, and Pet3HA is initiated by the formation of a hairpin
structure at the autochaperone domain and continues until the
long disulfide-bonded loop or inflexible structure in D2A is
reached, thereby jamming the translocator pore and preventing
further transport of the passenger domain. Thus, it is conceiv-
able that for Pet1HA, the disulfide-bonded loop containing the
HA epitope is located in the periplasmic space when expressed
in wild-type cells. Furthermore, we hypothesized that if a hair-
pin conformation was adopted, the C-terminal portion of the
passenger domain would be exposed on the bacterial cell sur-
face. To test these hypotheses, we generated pBADPet1HA-
FLAG, a construct that encodes Pet1HA-FLAG, a Pet1HA
derivative harboring a FLAG epitope tag (DYKDDDDK) in the
C terminus of its passenger domain in addition to the HA
epitope tag already present in D2A. The FLAG epitope tag was
inserted between 2 residues (Gly-837 and Phe-838) that are
present in a long loop projecting from the -helix (supplemen-
tal Fig. S3A). Importantly, insertion of a FLAG epitope tag at
this location did not abolish Pet secretion in a dsbA back-
ground (supplemental Fig. S3B). As an additional control,
pBADPetSB was created to encode PetSB, a Pet derivative con-
taining mutations in the amino acid residues that are responsi-
ble for autocatalytic cleavage of the passenger domain from the
translocator (Asn-1018 and Asp-1115); this secretion-blocked
variant translocates the passenger domain to the cell surface,
but it is not processed or released from the cell. A further deriv-
ative, PetSB-FLAG, was also constructed such that a FLAG
epitope was positioned in the exact location as that in
Pet1HA-FLAG.
To stain for surface exposure of the passenger domain, indi-
rect immunofluorescence microscopy of live cells was used to
reduce the possibility of cell lysis, and thus cells were expected
to remain intact and impermeable toward antibodies (43).
Fixed and permeabilized cells were used to stain for passenger
exposure in the periplasm. We probed stalled intermediates
with either anti-HA tag or anti-FLAG tag antibodies as well as
anti-Pet passenger antibody as an additional control to demon-
strate selective labeling of periplasmic and surface-exposed Pet
passenger domain, respectively. As expected, live cells express-
ing Pet1HAandPet1HA-FLAGdidnot labelwith anti-HAanti-
bodies, and the HA epitope could be detected only if the cells
were first permeabilized (Fig. 4, middle panels, compare
Pet1HA and Pet1HA (permeabilized) with Pet1HA-FLAG and
Pet1HA-FLAG (permeabilized)). These data indicate that the
disulfide-bonded segment containing the HA epitope was
localized in the periplasm and largely confirmed the preserva-
tion of OM integrity. As a positive control for anti-HA tag anti-
body labeling, we used PetL4HA, which has an HA epitope in
extracellular L4 of the Pet -barrel (Fig. 4, middle panel,
PetL4HA). Labeling of Pet1HA and Pet1HA-FLAG with anti-
Pet passenger antibodywas suggestive of partial exposure of the
passenger domain of these trapped intermediates at the cell
surface and was comparable with that of the positive control,
PetSB. Strong labeling of Pet1HA-FLAG with anti-FLAG tag
antibody was also indicative of exposure of the C terminus of
the passenger domain at the cell surface with labeling compa-
rable with that of the positive control, PetSB-FLAG (Fig. 4, right
panels, compare Pet1HA-FLAG with PetSB-FLAG). Collec-
tively, these data demonstrate that Pet1HA and Pet1HA-FLAG
are bona fide translocation intermediates that accumulate in
theOM in a hairpin conformationwith theN terminus exposed
in the periplasm, whereas the C terminus of the passenger
domain is exposed at the cell surface (supplemental Fig. S4).
Stalled Intermediates Interact with BamA and BamD during
OMTranslocation—We recently demonstrated that BamAand
BamD are the only components of the BAM complex essential
for ATbiogenesis (8). This is further supported by in vivo cross-
linking experiments documenting direct BamA/BamD-AT
interactions (5, 10–12). Because AT secretion is extremely
rapid (31), we performed co-immunoprecipitation assays via
mild chemical cross-linking of proteins using formaldehyde to
determine whether our stalled intermediates specifically inter-
act with BamA and BamD in vivo during active translocation.
Chemical cross-linking facilitates the identification of acces-
FIGURE 4. Stalled intermediates possess a hairpin conformation that can
bedetectedusing fluorescencemicroscopy.TOP10 cells expressingempty
vector (EV), PetSB, PetSB-FLAG, PetL4HA, Pet1HA, andPet1HA-FLAGwere col-
lected 1 h after induction with 0.02% arabinose and subjected to indirect
immunofluorescence using anti-Pet passenger antibody (left panels), anti-HA
antibody (middle panels), or anti-FLAG tag antibody (right panels; pseudo-
colored red) and an Alexa Fluor 488-labeled conjugate (all panels). In the case
of Pet1HA and Pet1HA-FLAG, half of the samples were fixed and permeabi-
lized prior to labeling. Corresponding fields are also shownby phase contrast
microscopy. Completely black boxes indicate that staining was not assessed.
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sory factors assisting in translocation of passenger domains
across the OM (5, 22) and stabilizes these otherwise transient
protein-protein interactions in whole cells. After cross-linking,
E. coli cells expressing Pet48aa, Pet1HA, and Pet1HA-FLAG
were harvested, spheroplasted, and lysed, and membrane pro-
teins were co-purified with immobilized anti-Pet passenger
domain antibody. Sample buffer containing DTT was used to
elute stalled intermediates and interacting proteins and to dis-
sociate the cross-linked proteins. Cells not expressing Pet or
cells expressing wild-type Pet or the secretion-blocked variant
(PetSB) were used as controls. Western immunoblotting using
anti-Pet passenger, -BamA, or -BamDantibodies of eluates sep-
arated on gradient 4–12% Bis-Tris gels revealed that BamA
specifically cross-links to and co-purifies with all three stalled
intermediates that localized to the OM as high molecular mass
intermediates of130 kDa and not with wild-type Pet or PetSB
(Fig. 5A). These results exemplify the transient nature of the
BamA-Pet interaction, which appears to transpire only during
active translocation of the Pet passenger domain across the
OM. In addition, all three stalled intermediates sequestered
BamD, and this protein was also present in the eluates from
cross-linked wild-type Pet and PetSB, albeit at considerably
reduced levels (Fig. 5B).
DISCUSSION
The dimensions of the translocator pore and the mechanism
of OM translocation have direct implications for the degree of
passenger domain folding prior to secretion. It is universally
accepted that the fully folded AT -domains, observed by x-ray
crystallography, have pore diameters too narrow to accommo-
date significant structural elements within the passenger
domains (14–18). However, translocation of sizable folded
domains comprising disulfide-bonded segments of heterolo-
gous passenger domains has been reported (30–32). In con-
trast, most available evidence directly or indirectly indicates
that OM translocation is dependent on a passenger domain
conformation, which does not possess significant structural
elements, is largely unfolded, and differs from the final protein
structure (4, 11, 20, 21, 23, 49). The conflict between these data
may arise through the use of non-native passenger domains and
thus non-native structural elements. To address the dichoto-
mous nature of these datasets, the secretion of anAT passenger
domain that possesses a disulfide-bonded structural element
formed by native Cys residues was examined.
We and others had previously noted the general paucity of
Cys residues within the passenger domains of ATs (46). Here,
updated bioinformatic analyses of the ATs confirmed that
when present, Cys residues are juxtaposed with an average dis-
tance of 7 residues and maximum distance of 17 residues
(supplemental Table S3). The exceptions to this observation are
the polymorphic ATs of Chlamydia (45). Interestingly,
although Chlamydia do contain DsbA orthologues, which are
expected to function to oxidize Cys-rich periplasmic proteins
to form a substitute for peptidoglycan in the elementary body,
the novel chlamydial periplasmic oxidoreductase, DsbH, may
be responsible for maintaining a reducing periplasm (50).
Although there is no direct evidence, it is tempting to speculate
that DsbH keeps the polymorphic ATs of Chlamydia in a
reduced state in the periplasm to maintain their translocation
competence. These data strongly suggest that AT proteins have
evolved to lack large disulfide-bonded loops within their pas-
senger domains, but that they maintain the ability to secrete
passenger domains with small disulfide-bonded structural ele-
ments. Certainly, the formation of small disulfide-bonded loops
between closely spaced endogenous Cys residues does not to
interfere with passenger domain translocation (24, 25, 31, 51).
To systematically determine the maximum length of a disul-
fide-bonded loop that does not interfere with passenger
domain translocation, we analyzed the secretion of Pet. The Pet
passenger domain possesses a pair of native Cys residues that
form a disulfide bond, obviating the need for the introduction
of heterologous domains that might obscure the data. Analysis
of Pet and its single-site mutant derivatives demonstrates an
apparent inverse relationship between the length of a disulfide-
bonded loop and secretion efficiency and shows that the longest
disulfide-bonded loop that does not significantly interfere with
OM translocation of the Pet passenger domain is formed
between a Cys pair separated by 18 residues. This is a distance
that is in agreement with the preference for shorter connec-
tions in globular proteins where 49% of all disulfide bonds are
formed between Cys pairs separated by less than 24 residues
(52) and is not far removed from the maximum distance sepa-
rating endogenous Cys pairs within some wild-type passenger
domains. Thus, our results suggest that when present, Cys pairs
are intrinsically closely spaced to prevent congestion of the
translocator pore by large disulfide-bonded regions.
Having demonstrated that the AT -domain is capable of
secreting passenger domains with disulfide-bonded loops con-
taining 18 amino acids, it was perplexing to find that a smaller
loop containing an HA epitope tag insertion obstructed OM
translocation of the Pet passenger. However, we demonstrated
that it is the rigid and/or bulky nature rather than the position
or length of the HA epitope tag insertion that is the critical
parameter for translocation competence, indicating that only
flexible regions with minimal tertiary structure are compatible
with the AT pathway. This observation could explain the dis-
crepancy in OM translocation efficiencies observed by others
for disulfide-bonded heterologous passenger domains (29–36).
FIGURE 5. Stalled intermediates interact with BamA and BamD during
OM translocation. TOP10 cells expressing empty vector (EV), wild-type Pet,
PetSB, Pet48aa, Pet1HA, and Pet1HA-FLAG were harvested, spheroplasted,
and lysed. Proteins were co-purified with anti-Pet passenger domain anti-
body, separated on a gradient 4–12%Bis-Tris gel inMES buffer, and analyzed
byWestern immunoblotting using anti-Pet passenger, anti-BamA (A), or anti-
BamD (B) antibodies. A whole cell lysate (WCL) was included as an additional
control for BamD. Generally, only the three high molecular weight stalled
intermediates (Pet48aa, Pet1HA, and Pet1HA-FLAG) co-purify with the BAM
proteins.M, molecular mass markers.
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Indeed, our observations are consistent with the findings of
Jong et al. (28), who showed that replacement of D2 with a
145-amino acid calmodulin moiety completely blocked the
secretion ofHbp into the extracellularmilieuwhen calciumwas
added to the growth medium to induce a conformational
change in calmodulin in the form of a rigid dumbbell structure.
The data are also consistent with observations by Rutherford et
al. (53), who demonstrated that a folding-defective derivative of
MalE could be translocated across theOMbut that nativeMalE
could not. These combined data strongly suggest the passenger
must be maintained in a linear conformation with minimal
structure to remain secretion-competent.
Based largely upon the contrasting observations for the
secretion of disulfide-bonded segments, two prevailing models
of passenger domain translocation have developed. The first
encompasses translocation of a passenger domain through a
folded AT -domain pore via formation of a hairpin structure
where a static strand is sequestered in the -barrel lumen,
whereas a sliding strand traverses the pore. Given the size con-
straints of the -barrel pore, the passenger domain would have
to be maintained in an extended conformation during the
translocation event to prevent congestion. In this study, we
determined the topology of bona fide translocation intermedi-
ates showing that they accumulate in the OM in a hairpin con-
formation with the N terminus of their passenger domains
exposed in the periplasm, whereas their C terminus is exposed
at the bacterial cell surface (supplemental Fig. S4). This result,
in conjunction with the data demonstrating that secretion
requires an unfolded passenger domain in a linear conforma-
tion, strongly supports the hairpin model of biogenesis.
The second model of passenger domain translocation sug-
gests a role for BamA in maintaining an “open state” AT -do-
main with complete folding occurring only after passenger
domain translocation is complete; this model allows for the
secretion of larger structural elements and glycosylated passen-
ger domains. In support of this, several studies have demon-
strated that BamA is essential for AT biogenesis (5–8). The
interaction of our stalled intermediates with BamA in vivo dur-
ing active translocation confirmed these observations.
Recently, we demonstrated that BamD was also essential for
passenger domain secretion, but that loss of the BamB, BamC,
and BamE components had no effect on AT passenger secre-
tion (8). The interaction of our stalled intermediates with
BamD in vivo during active translocation confirmed these
observations. Interestingly, interaction of BamD with the AT
stalled intermediates was more prolonged than binding of
BamA. These findings are consistent with a recent study dem-
onstrating that the interaction of BamDwith the AT -domain
persists after passenger domain translocation, cleavage, and
secretion of the passenger (12). These authors also noted pro-
longed interaction of the AT -barrel with BamB. However,
BamB is not required for the insertion of Hbp or Pet -barrels
into theOMas folded species nor for translocation or folding of
these passenger domains (5, 8). Furthermore, ATs are readily
assembled inNeisseria sp., which lack BamB. Thus, we propose
that the EspP-BamB and Hpb-BamB interactions observed in
vivo (5, 10) are nonspecific and a consequence of BamB inde-
pendently interacting with BamA.
The above data support a model in which the AT -barrel
docks with BamA and is maintained in an open and loosely
folded conformation during passenger domain translocation
withBamDrequired at a later step ofATbiogenesis thanBamA.
Once the passenger domain is translocated, cleaved, and
secreted, BamDwould disassociate, triggering sealing of theAT
-domain and its folding into a stable barrel. This model con-
flicts with the simplistic hairpin model. The models may, how-
ever, be reconciled using recent observations for fimbrial bio-
genesis via the chaperone-usher pathway. Remarkably, Phan et
al. (54) demonstrated that to allow translocation of the pilin
subunit, the usher -barrel rearranges from a kidney-shaped
pore to a wider, near circular pore; such conformational con-
tortions in -barrel proteins were unprecedented as -barrels
were considered rigid structures. Notably, the AT barrel pos-
sesses a similar oval conformation to the usher; thus, we pro-
pose that the AT barrel adopts a circular conformation during
passenger domain translocation, which allows migration of
passenger domains with small disulfide-bonded segments and
glycosyl moieties through the pore, and only after translocation
and cleavage of the passenger domain are complete does the
-barrel “collapse” to the oval-shaped structure observed by
crystallography. In this model, a stalled, trapped intermediate
cannot shift to its final conformation and cannot be released
from the BAM complex, a hypothesis consistent with the pro-
longed interactions observed between translocation-stalled
intermediates and BamA and BamD.
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Table S1. Plasmids used in this study 
Plasmids Relevant description Reference 
pUC57 Cloning vector, ampicillin resistant  GenScript 
pUC57SB pUC57 derivative containing a de novo synthesized SB SalI-KpnI 
fragment 
GenScript / 
This study 
pUC57ΔD2A pUC57 derivative containing a de novo synthesized ΔD2A SpeI- 
XbaI fragment 
GenScript / 
This study 
pUC571HA pUC57 derivative containing a de novo synthesized D2A1HA epitope 
SpeI-BsrGI fragment 
GenScript / 
This study 
pUC572HA pUC57 derivative containing a de novo synthesized D2A2HA epitope 
SpeI-BsrGI fragment 
GenScript / 
This study 
pUC573HA pUC57 derivative containing a de novo synthesized D2A3HA epitope 
SpeI-BsrGI fragment 
GenScript / 
This study 
pUC5748aa pUC57 derivative containing a de novo synthesized D2A48aa SpeI-
BsrGI fragment 
GenScript / 
This study 
pUC57L4HA pUC57 derivative containing a de novo synthesized L4HA HpaI-
EcoRI fragment 
GenScript / 
This study 
pBADHisA  Arabinose-inducible expression vector, ampicillin resistant Invitrogen 
pBADPet pBADHisA derivative expressing de novo synthesized Pet (39) 
pBADPetSB pBADPet derivative containing a SalI-KpnI fragment subcloned 
from pUC57SB where putative autocatalytic residues N1018 and 
D1115 were mutated to Gly to create a secretion blocked variant 
This study 
pBADPetΔD2A pBADPet derivative containing a SpeI-XbaI fragment subcloned 
from pUC57ΔD2A that contains three Gly residues between H1 and 
S50 to express Pet with a D2A deletion 
This study 
pBADPet1HA pBADPet derivative containing a SpeI-BsrGI fragment subcloned 
from pUC571HA to express Pet with one HA epitope between 
residues E14 and F15 
This study 
pBADPet2HA pBADPet derivative containing a SpeI-BsrGI fragment subcloned 
from pUC572HA to express Pet with two HA epitopes between 
residues E14 and F15 
This study 
pBADPet3HA pBADPet derivative containing a SpeI-BsrGI fragment subcloned 
from pUC573HA to express Pet with three HA epitopes between 
residues E14 and F15 
This study 
pBADPetC12G pBADPet derivative with C12 mutated to Gly to disturb the Cys pair 
within Pet and obstruct disulfide bond formation 
This study 
pBADPetC12G/ 
C17G 
pBADPet derivative with C12 and C17 mutated to Gly to disturb the 
Cys pair within Pet and obstruct disulfide bond formation 
This study 
pBADPet6aa pBADPet derivative with N10 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 6 amino acids  
This study 
pBADPet8aa pBADPet derivative with K8 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 8 amino acids  
This study 
pBADPet10aa pBADPet derivative with T6 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 10 amino acids  
This study 
pBADPet12aa pBADPet derivative with F4 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 12 amino acids  
This study 
pBADPet14aa pBADPet derivative with A2 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 14 amino acids  
This study 
pBADPet16aa pBADPet derivative with D-1 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 16 amino acids  
This study 
pBADPet18aa pBADPet derivative with A-3 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 18 amino acids  
This study 
pBADPet20aa pBADPet derivative with G-5 mutated to C and C12 to G so that the 
Cys pair in Pet are separated by 20 amino acids  
This study 
pBADPet48aa pBADPet derivative containing a SpeI-BsrGI fragment subcloned 
from pUC5748aa containing C12/C17 mutated to G and H1/S50 to C so 
that the Cys pair in Pet are separated by 48 amino acids 
This study 
pBADPet9G pBADPet derivative with a nine 9 amino acid Gly linker inserted in 
Pet between E14 and F15  
This study 
pBADPet1HA-
FLAG 
pBADPet1HA derivative with one FLAG epitope inserted in Pet 
between residues G837 and F838 
This study 
pBADPetSB-FLAG  pBADPetSB derivative with one FLAG epitope inserted in Pet 
between residues G837 and F838 
This study 
pBADPetL4HA pBADPet derivative containing a HpaI-EcoRI fragment subcloned 
from pUC57L4HA with one HA epitope inserted in loop 4 of the Pet 
β-barrel between residues G1184 and M1185   
This study 
Note that the numbers next to the Cys residues correspond to their position relative to D2A (from H1 to 
S50) and not the full length protein (from H575 to S624). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Primers used in this study 
Primer Sequence Reference 
SpeIFw 5’-CCACTAGTTATGCAGGGTCACGCGACCG-3’ This study 
BsrGIRv 5’-GCTGTACAGGTCGATGTACGCGGTTTTG-3’ This study 
BsrGIFw 5’-CCTGTACAGCGGTAAAAACATCACCGGC-3’ This study 
SalIRv 5’-TGAAGTCGACCAGCAGCAGGTTGTTCGC-3’ This study 
MPN10C/C12G(6-aa) 5’-GCGATCTTCCGTACCACCAAAACCTGCAACGGTCCGGAA 
TTTCTGTGCGGTGTTG-3’ 
This study 
MPK8C/C12G(8-aa) 5’-CCACGCGATCTTCCGTACCACCTGCACCAACAACGGTCC 
GGAATTTCTGTGCGGTGTTG-3’ 
This study 
MPT6C/C12G(10-aa) 5’-GACCGACCACGCGATCTTCCGTTGCACCAAAACCAACA 
ACGGTCCGGAATTTCTGTGCGGTGTTG-3’ 
This study 
MPF4C/C12G(12-aa) 5’-GTCACGCGACCGACCACGCGATCTGCCGTACCACCAAA 
ACCAACAACGGTCCGGAATTTCTGTGCGGTGTTG-3’ 
This study 
MPA2C/C12G(14-aa) 5’-GCAGGGTCACGCGACCGACCACTGCATCTTCCGTACCAC 
CAAAACCAACAACGGTCCGGAATTTCTGTGCGGTGTTG-3’ 
This study 
MPD-1C/C12G(16-aa) 5’-GTTATGCAGGGTCACGCGACCTGCCACGCGATCTTCCGT 
ACCACCAAAACCAACAACGGTCCGGAATTTCTGTGCGGTGT
TG-3’ 
This study 
MPA-3C (18-aa) 5’-GCGCCACTAGTTATGCAGGGTCACTGCACCGACCACGCG 
ATCTTCCGTACC-3’ 
This study 
MPG-5C (20-aa) 5’-CAAAAACGCGCCACTAGTTATGCAGTGCCACGCGACCGA 
CCACGCGATCTTCC-3’ 
This study 
MPC12G 5’-CTTCCGTACCACCAAAACCAACAACGGTCCGGAATTTCT 
GTGCGGTGTTGAC-3’ 
This study 
MPC17G 5’-CCAACAACGGTCCGGAATTTCTGGGCGGTGTTGACTGGG 
TTACCCGTATC-3’ 
 
MP9G 5’-CCACCAAAACCAACAACTGCCCGGAAGGTGGCGGTGGC 
GGTGGCGGTGGCGGTTTTCTGTGCGGTGTTGACTGGGTTAC-
3’ 
This study 
MP1HA-FLAG 5’-CGCTGGCGATGCTGGACGGTGATTATAAAGATGATGATGAT 
AAATTCGACACCTCTTACCAGGG-3’ 
This study 
Restriction enzyme sequences are in bold font, site-directed mutations are underlined and insertion 
sequences are italicized. Note that the numbers next to the Cys residues correspond to their position 
relative to D2A (from H1 to S50) and not the full length protein (from H575 to S624). 
 
 
 
 
 
 
 
Table S3. Cys pairs within passenger domains of selected ATs 
Protein Organism Function No. of 
Cys 
Distance between 
Cys pairs 
Accession 
no. 
SPATEs 
EspC E. coli Toxin 3 13/6 AAC44731 
EspP E. coli Toxin 2 9 CAA66144 
Pet E. coli Toxin 2 4 AAC26634 
Sat E. coli Toxin 2 5 AAG30168 
SigA S. flexneri Toxin 2 5 AAF67320 
RpeA E. coli Colonization factor 2 10 AAT36311 
Vat E. coli Toxin 2 11 AAO21903 
Non-SPATEs 
AlpA H. pylori Adhesion 2 16 CAB05386 
AlpB H. pylori Adhesion 2 17 BAJ59997 
ApeE S. enterica Esterase 2 8 AAC38796 
App N. meningitidis Adhesion 2 10 CAC14670 
AusI/MspA N. meningitidis Adhesion 4 10/9 ABB99955/ 
NP_274990 
AutA N. meningitidis Unknown 2 4 CAB89117 
EstA P. aeruginosa Cell mobility, biofilm 
formation, esterase 
2 5 AAB61674 
Hap H. influenzae Adhesion 2 10 P45387 
IcsA S. flexneri Intracellular movement 3 3 AAA26547 
IgA1 H. influenzae Protease 2 10 P45386 
IgA1 N. gonorrhoeae Protease 2 10 P09790 
IgA1 N. meningitidis Protease 2 10 CAA57857 
Lip-1 X. luminescens Lipase 2 8 P40601 
McaP M. catarrhalis Adhesion, lipase, esterase  2 11 AAP97134 
NalP N. meningitidis Cleavage of ATs  4 6/6 AAN71715 
PmpD C. trachomatis Adhesion 24 NA O84818 
Pmp20 C. pneumoniae Adhesion 14 NA Q9Z812 
PspA P. fluorescens Unknown 2 6 BAA36466 
PspB P. fluorescens Unknown 4 6/4 BAA36467 
SabA H. pylori Adhesion 4 5/4 AAD06240 
SphB1 B. pertussis Cleavage of FHA  2 6 AJ318229 
Ssa1 P. haemolytica Unknown 2 6 AAA80490 
Ssp S. marcescens Protease 4 6/4 P09489 
Ssp-h1 S. marcescens Unknown 4 6/4 BAA33455 
Ssp-h2 S. marcescens Unknown 4 6/4 BAA11383 
VacA H. pylori Toxin 2 10 Q48247 
FHA, filamentous hemagglutinin, a two-partner secretion protein from B. pertussis; NA, not assessed.  
 
 
 
 
Supplementary Figure Legends  
Fig. S1. Alignment demonstrating that D2A (shown in bold font) and the conserved Cys residues (shown 
in bold font and underlined) are present only in cytotoxic SPATE proteins. The conserved stable platform 
present in all SPATE proteins is underlined. Note that numbers correspond to the position of D2A relative 
to the full length protein (from H575 to S624). 
 
Fig. S2. A three-dimensional model of the Pet passenger domain showing D1 and the β-helix in blue, 
D2A in green and boxed with solid lines, the Cys pair in red spheres, and the semi-conserved stable 
platform in yellow sticks and boxed with broken lines. The positions of the Cys pair in Pet6aa to Pet48aa 
are also shown. 
 
Fig. S3. A FLAG epitope tag in the C-terminus of the Pet passenger domain does not abolish secretion. 
(A) A three-dimensional model of the Pet passenger domain showing a FLAG epitope tag (yellow 
spheres) inserted between two residues (G837 and F838) that are present in a long loop projecting from 
the β-helix. (B) SDS-PAGE analysis of TCA-precipitated culture supernatant fractions harvested after 
growth of TOP10 ΔdsbA expressing wild-type Pet (WtPet) and Pet1HA-FLAG. M; molecular weight 
markers. 
 
Fig. S4. A schematic description of stalled versus secreted passenger domains. In an oxidizing 
environment (wild-type cells; left), OM translocation of Pet1HA-FLAG is initiated by the formation of a 
hairpin structure and continues until the inflexible HA epitope (green rectangle) in D2A is reached 
thereby jamming the translocator pore and preventing further transport of the passenger domain. As such, 
intermediates accumulate in the OM in a hairpin conformation with the N-terminus (containing the HA 
epitope) exposed in the periplasm while the C-terminus of the passenger domain [containing the FLAG 
epitope (red box)] is exposed at the cell surface. In a reducing environment (ΔdsbA cells; right), OM 
translocation is unaffected as the HA epitope is not trapped within a disulfide-bonded loop and is not 
innately resistant to secretion via the AT translocator. Once on the bacterial cell surface, the protein folds 
into its native conformation, is processed and secreted into the extracellular environment.   
 
 
 
 
 
 
Fig. S1 
Pet    QGHATDHAIFRTTKTNNCP-----EFLCGVDWVTRIKNAENSVNQKNKTTYKSNNQVSDLSQPDWETR  
Sat    QGHATEHAIFRSS-ANHCSL----VFLCGTDWVTVLKETESSYNKKFNSDYKSNNQQTSFDQPDWKTG 
EspP   QGHATEHAIYRDG-AFSCSLPAPMRFLCGSDYVAGMQNTEADAVKQNGNAYKTNNAVSDLSQPDWETG  
SigA   QGHATEHAIFKEG-NNNCPIP----FLCQKDYSAAIKDQESTVNKRYNTEYKSNNQIASFSQPDWESR  
EspC   AGTCLHLMLFLERVGVTCMLP---GVICEKDYVSGIQQQENSANKNNNTDYKTNNQVSSFEQPDWENR  
Tsh    QGHPVIHAYNTQSVADKLAAS---------------------------GDHSVLTQPTSFSQEDWENR 
Hbp    QGHPVIHAYNTQSVADKLAAS---------------------------GDHSVLTQPTSFSQEDWENR  
Vat    QGHPVIHASTSQSIANTVSSL---------------------------GDNSVLTQPTSFTQDDWENR  
Pic    QGHPVIHASISG------------------------------------------SAPVSLNQKDWENR  
SepA   QGHPVIHAG----------------------------------------------TTTSSSQSDWETR  
EatA   QGHPVIHAG----------------------------------------------MTTSAGQSDWENR  
EpeA   QGHPVIHA----------------------------------------------GVGVSAEQNDWETR 
EspI   QGHPVIHA----------------------------------------------GQTVSASQSDWENR 
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